  Metoprolol Tartrate (Lopressor, Toprol-XL, and Betaloc) section { margin-bottom: 20px; } table { border-collapse: collapse; } table, tr, th, td { border: 1px solid black; } th, td { padding: 0px 8px 0px 8px; text-align: left; vertical-align: top; } h3, p, ol.custom-counter, li { margin: 0px; padding: 0px; } .text-red { color: red; } .text-black { color: black; } ul.custom-dash { list-style: none; padding-left: 0; margin: 0; } ul.custom-dash > li { display: flex; align-items: flex-start; } ul.custom-dash > li::before { content: "–"; margin-right: 0.5em; flex-shrink: 0; line-height: 1; } ul.custom-dash > li > \*:not(::before) { flex: 1; } ul.custom-dash > li.no-dash::before { content: ""; width: 1em; margin-right: 0.5em; flex-shrink: 0; } /\* Change the ol style \*/ ol.custom-counter { list-style: none; padding-left: 0; counter-reset: custom calc(var(--start, 1) - 1); } ol.custom-counter li { counter-increment: custom; margin-bottom: 5px; } ol.custom-counter li::before { content: counter(custom) ") "; } /\* This is just for this file \*/ ul.custom-bullet-arrow { list-style: none; padding-left: 0; margin: 0; } ul.custom-bullet-arrow > li { display: flex; align-items: flex-start; } ul.custom-bullet-arrow > li::before { content: "↑"; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet-arrow > li.no-arrow::before { content: ""; width: 0.5em; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet\_arrow ul { list-style-type: disc; padding-left: 1.5em; margin-top: 0.5em; } img.resized-200 { width: 200px; height: auto; } img.resized-400 { width: 400px; height: auto; } img.resized-600 { width: 600px; height: auto; } .mb-10px { margin-bottom: 10px; } .mb-20px { margin-bottom: 20px; } .mt-10px { margin-top: 10px; } .mt-20px { margin-top: 20px; } .reference-notes { font-size: 11px; } .text-indent-45px { text-indent: 45px; } .text-bold { font-weight: bold; } .text-italic { font-style: italic; } .text-center { text-align: center; }

### Metoprolol Tartrate (Lopressor, Toprol-XL, and Betaloc)

**Beta:** B

**Bathmatropy:** The degree of excitability or irritability of heart muscle or neurons (action potentials).

**Lusitropy:** The heart's ability to relax quickly, which is essential for proper diastolic filling and overall heart function.

<table><tbody><tr><th style="width: 160px;">Class</th><td style="width: 450px;"><p>Beta-adrenergic antagonist</p></td></tr><tr><th>Subclass</th><td><p>Cardioselective B1 blocker</p></td></tr><tr><th>Quick notes</th><td><p>The primary function is to ↓ HR and BP.</p><p>It competitively prevents inotropic and chronotropic responses to adrenergic stimulation from epinephrine and norepinephrine.</p><p>Slower onset and longer duration than Esmolol</p><p>Large doses may antagonize B2 receptors in the lungs (may cause ↑ wheezing) -rare.</p><p>A common beta blocker to administer IV preoperatively to CAD</p><p>patients who are not beta-blocked.</p><p>↓ HR, ↑ diastolic perfusion time</p><p>Can be administered PO or IV</p><p>Metoprolol is available as two different salts: metoprolol tartrate and metoprolol succinate.</p></td></tr><tr><th>FDA-approved Indications</th><td><p>Hypertension</p><p>Angina pectoris</p><p>Myocardial infarction</p><p class="mb-10px">Heart failure</p><p class="text-bold">Off-label indications:</p><p>Tachyarrhythmias: A-fib and SVT</p><p>Ventricular tachycardia</p><p>Thyrotoxicosis</p></td></tr><tr><th>Action</th><td><p>↓ sinus rate, AV node conduction, and CO</p><p>↓ inotropy, ↓ bathmatropy, ↑ lusitropy, resulting in ↓ myocardial O2 demand and myocardial ischemia during exercise.</p><p>See details below this table</p></td></tr><tr><th>Adult IV dose</th><td><p>2.5 to 5 mg Q5 minutes up to a total dose of 15 mg</p></td></tr><tr><th>Adult PO dose</th><td><p>25-100 mg QD</p><p>Only 50% bioavailability after first-pass metabolism</p><p>Tablets up to 100 mg are available</p></td></tr><tr><th>Peds Doses</th><td><p>Safety and effectiveness in pediatric patients have not been established.</p><p><b>Peds IV: </b>Off-label</p><p><b>Initial dose: </b>0.01–0.2 mg/kg IV (maximum 5 mg per dose)</p><p class="mb-10px">Administer slowly over at least 5 minutes</p><p class="text-bold">Peds PO:</p><p>6 Years or Older:</p><p>Initial dose: 1 mg/kg Q-day (not to exceed 50 mg orally once a day)</p><p>Maximum dose: 2 mg/kg (or 200 mg) orally once a day</p><p>Adult PO: Tablets up to 100 mg are available</p></td></tr><tr><th>Onset (IV)</th><td><p>1-2 minutes</p></td></tr><tr><th>Clinical Duration</th><td><p>IV: 5-8 hours</p><p>PO (extended relief) 24 hours</p></td></tr><tr><th>Elimination ½ life</th><td><p>3-4 hours</p></td></tr><tr><th>Enhance duration</th><td><p class="text-bold">CYP2D6 inhibitor drugs:</p><p>Paroxetine (Paxil)</p><p>Fluoxetine (Prozac)</p><p>Bupropion (Wellbutrin)</p><p>Citalopram and escitalopram</p><p>Propafenone</p><p>Quinidine</p><p>Amiodarone</p><p>Cimetidine</p><p>Diphenhydramine</p></td></tr><tr><th>Decrease duration</th><td><p class="text-bold">Drugs that ↑ the activity of CYP2D6:</p><p>Rifampin</p><p>Chlordiazepoxide</p><p>Certain anticonvulsants and antibiotics</p><p>People who are ultra-rapid metabolizers of the CYP2D6</p></td></tr><tr><th>Histamine release</th><td><p>No</p></td></tr><tr><th>Side effects</th><td><p>Dizziness and fatigue</p><p>Hypotension</p><p>bradycardia</p><p>Diarrhea, nausea, or stomach pain</p><p>Cold hands and feet</p><p>Depression, confusion, or memory problems</p><p>Insomnia, sleepiness, or nightmares</p><p>Dry mouth</p><p>Mild rash or itching</p></td></tr><tr><th>Metabolism</th><td><p>Hepatic, predominantly by CYP2D6, an enzyme that is absent in about 8% of Caucasians (poor metabolizers) and about 2% of most other populations.</p></td></tr><tr><th><p>Metabolites</p></th><td><p>α-hydroxymetoprolol and O-demethylmetoprolol (inactive)</p></td></tr><tr><th>Route of elimination</th><td><p>Approximately 95% renal, with less than 5% of the dose excreted unchanged in the urine by extensive metabolizers.</p></td></tr><tr><th>Protein bounds</th><td><p>12 %, albumin</p></td></tr><tr><th>Pregnancy</th><td><p>C</p></td></tr><tr><th>Breast feed</th><td><p>Considered safe. Small amount in breast milk</p><p>(0.07% of the maternal dose)</p><p>No evidence found to harm breastfeeding infants.</p></td></tr><tr><th>Breast feed</th><td><p>Phenylephrine may potentially reduce milk production</p><p>Nasal sprays or ophthalmic drops are less likely to harm individuals who are breastfeeding.</p></td></tr><tr><th>pH</th><td><p>Aqueous solution between 6.0 and 7.0</p></td></tr><tr><th>Contraindications</th><td><p>Severe bradycardia</p><p>Heart block greater than first degree</p><p>Cardiogenic shock</p><p>Decompensated cardiac failure</p><p>Sick sinus syndrome (unless a pacemaker is in place)</p><p>Hypersensitive</p></td></tr><tr><th>Reversal agents</th><td><p>None: Drugs that may counter the effects:</p><p>Glucagon</p><p>Intravenous fluids</p><p>Atropine</p><p>norepinephrine</p><p>epinephrine</p></td></tr><tr><th>Vol of distribution</th><td><p>3.2 to 5.6 L/kg</p></td></tr><tr><th>Distribution ½ life</th><td><p>12-15 minutes</p></td></tr><tr><th>Storage</th><td><p>Room temperature</p></td></tr></tbody></table>

| Name | B1 | B2 | A1 | ½ life  
(hours) | Metabolism | Onset  
IV | Duration  
(hours) |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Metoprolol  
(Lopressor) | + | 0 | 0 | 3-4 | Liver | 1-2 mins | 5-8 |
| Labetalol  
(Trandate) | + | + | + | 6 | Liver | 2-5 mins | 2-6 |
| Esmolol  
(Brevibloc) | + | 0 | 0 | 0.15 | RBC esterase | 1-2 mins | 10-20 minutes |
| Atenolol  
(Tenormin) | + | 0 | 0 | 6-9 | Renal | Within 5 mins | 12 |
| Propranolol  
(Inderal) | + | + | 0 | 3-4 | Liver | Within 5 mins | 2-5.5 |
| Carvedilol  
(Coreg) | + | + | + | 2-8 | Liver | Only PO | 12-24 |

Mechanism of action:

Metoprolol binds to the β-1 adrenergic receptors on the surface of the cardiac cells, especially in the SA node, AV node, and the ventricular myocardium.

1.  Metoprolol blocks catecholamine receptor activation of epinephrine or norepinephrine by competing for the same receptors, thereby reducing the intracellular signaling pathways mediated by cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA).
2.  Metoprolol ↓ the slope of phase 4 in the nodal action potential (spontaneous depolarization phase) that determines HR.
    
    This will ↓ the Na influx during this phase, thus slowing down the firing rate of the pacemaker cells and lowering the HR.
    
3.  Metoprolol prolongs the repolarization of phase 3 in the nodal action potential, which is the phase where potassium efflux restores the resting membrane potential.
    
    By delaying this phase, metoprolol increases the refractory period of the cardiac cells and reduces their excitability and conduction velocity.
    
4.  Metoprolol also ↓ the contractility of the ventricular myocardium by inhibiting the Ca influx through the L-type Ca channels, which PKA regulates.
    
    By ↓ the Ca availability for the sarcomeres, metoprolol ↓ affects the force of contraction and ↓ cardiac output.
    

Metoprolol

National Library of Medicine

StatPearls (accessed 09/2025)

Jason Morris; Ayoola O. Awosika; Alexis Dunham

https://www.ncbi.nlm.nih.gov/books/NBK532923/#:~:text=Absorption:%20Metoprolol%20is%20rapidly%20and%20completely%20absorbed,to%20extensive%20first%2Dpass%20metabolism%20in%20the%20liver.

Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Benfield P, Clissold SP, Brogden RN.

Drugs. 1986 May;31(5):376-429

Metoprolol Therapy and CYP2D6 Genotype

Medical Genetics Summaries, April 2017 (accessed 10/2025)

Laura Dean, MD and Megan Kane, PhD.

https://www.ncbi.nlm.nih.gov/books/NBK425389/

Metoprolol Succinate vs Tartrate: What's the difference between them?

Drugs.com (accessed 10/25)

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 19, 2024.

https://www.drugs.com/medical-answers/difference-between-metoprolol-tartrate-metoprolol-3509130/

Stoelting’s Pharmacology & Physiology in Anesthetic Practice 6th Ed, 2022

CH. 19; Sympatholytics, pp. 476, 479

Pamela Flood, James P. Rathmell

Metoprolol

Drugs and Lactation Database (LactMed®) accessed 09/2025

https://www.ncbi.nlm.nih.gov/books/NBK501156/#:~:text=Summary%20of%20Use%20during%20Lactation,200%20mg%20daily.%5B4%5D